Prominence Health Plan announced that its 7 Universal Health Services (UHS) Accountable Care Organizations (ACOs) revealed a continued trend of increased cost savings and improved quality in 2018 results.
Prominence Health Plan announced that its 7 Universal Health Services (UHS) Accountable Care Organizations (ACOs) revealed a continued trend of increased cost savings and improved quality in 2018 results.
A subsidiary of UHS, Prominence Health Plan’s 7 ACOs operate through a group of physicians who agree to reduce costs and increase quality within a value-based contract. These shared-savings agreements incentivize physicians to alter the healthcare cost curve, manage utilization, and promote high-quality care through a transition from volume-based payments to value-based payments. Participating providers are also incentivized as they can earn back part of the savings that they generate for Medicare by meeting preset spending goals.
In its published results, Prominence Health Plan detailed the effectiveness of its ACOs in saving Medicare $65.2 million and further earning $30 million for its 3000 participating physicians. Kamal Jemmoua, MS, CEO of Prominence Health Plan, described the ACO concept as a change that has been long overdue within applied practices of primary care medicine. “The model rewards both the patient and physician as the patient receives better healthcare and the physician is financially incentivized for keeping them as healthy as possible,” said Jemmoua.
Notable highlights from the report include several UHS ACOs that were included in state rankings based on attributed cost savings:
“This success is the outcome of intentional partnership within UHS communities, empowering local primary care clinicians with the necessary data and resources to provide high quality, high-value care,” said Jemmoua.
The ACO program was established by CMS to improve the quality of care and lower costs for Medicare beneficiaries. Since being implemented in 2013, ACOs have saved Medicare $2.66 billion.
UHS ACOs employ their own distinct practice through focusing on primary care with community partnership in post-acute and specialty care. As ACOs are normally physician-led, the hospital-sponsored aspect to UHS’ version differentiates it from other ACOs. The hospitals provide capital funding, partnership in downside risk, and integrated ACO-friendly hospital initiatives focused on avoiding unnecessary utilization and increasing communication with ACO providers. Administrative oversight and data analytics are additionally provided by UHS for ACO operations.
Robert Sanders, MD, internal medicine physician for TexomaCare, noted that the UHS ACO program affiliated with his practice has generated an improvement of care for all patients. “The ACO has encouraged our providers to focus on specific high-value activities for our patients, as well as consider non-traditional social and environmental factors when addressing their overall care,” said Sanders.
Looking Back on ISPOR 2024: Hot Policy Topics, Welcome Focus on Employers, and More
May 10th 2024Kimberly Westrich, MA, chief strategy officer of the National Pharmaceutical Council, reflects on the most valuable learnings from the 2024 meeting of ISPOR—The Professional Society for Health Economics and Outcomes Research, including lively discussions of the Inflation Reduction Act and workshops on value assessment.
Read More
Examining Low-Value Cancer Care Trends Amidst the COVID-19 Pandemic
April 25th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the April 2024 issue of The American Journal of Managed Care® about their findings on the rates of low-value cancer care services throughout the COVID-19 pandemic.
Listen
Oncology Onward: A Conversation With Penn Medicine's Dr Justin Bekelman
December 19th 2023Justin Bekelman, MD, director of the Penn Center for Cancer Care Innovation, sat with our hosts Emeline Aviki, MD, MBA, and Stephen Schleicher, MD, MBA, for our final episode of 2023 to discuss the importance of collaboration between academic medicine and community oncology and testing innovative cancer care delivery in these settings.
Listen
Industry Experts Tackle Specialty Drug Access Challenges for Employer Benefit Plans
May 2nd 2024Representatives from ICON plc and Symphony Health joined forces at AXS24 to discuss the challenges of managing high-cost specialty drugs and how they influence self-funded employer benefit plan design and employee access to specialty medications.
Read More
Forging a Patient-Centric Path to Revolutionize and Redefine Value-Based Care
April 30th 2024Optum Life Sciences and Takeda Pharmaceuticals are partnering on an innovative virtual care pilot program for inflammatory bowel disease meant to both continue the mission of the current value-based health care landscape and raise the bar for personalized care delivery optimization.
Read More